Technology & Software Global On demand · 24-48h

Global Digital Obesity Management Market Strategic Research Report

Global Digital Obesity Management Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Digital Obesity Management Market
$6.31B2025
9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Weight Tracking and Management Software, Ai-Based Dietary Analysis Software, Exercise Management Software, Health Data Analysis Platform, Digital Therapeutics (DTx) Platform, Others

By Application: Obesity Management for Adults, Obesity Management for Children and Adolescents, Obesity Management for the Elderly, Management of Obesity with Diabetes, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: WW International, Noom, Teladoc Health, Omada Health, Hims & Hers Health, Found Health, Lark Health, MyFitnessPal, Lose It, HealthifyMe, Lifesum, WellDoc, Better Therapeutics, Oviva AG, Lifesum AB, Liva Healthcare, CureApp Inc, Asken Inc, Alibaba Health Information Technology, Boohee

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 127 pages
Market size 2025
$6.31B
Billion USD
Forecast CAGR
9%
2025-2032
Forecast 2032
$11.5B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Digital Obesity Management market size is predicted to grow from US$ 6,310 million in 2025 to US$ 11,471 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.

Digital Obesity Management refers to a comprehensive health management model that utilizes technologies such as artificial intelligence (AI), big data, mobile health applications, wearable devices, telemedicine, and digital therapeutics to provide long-term, personalized, and intelligent management for individuals with obesity. The system typically encompasses functions such as monitoring weight and body metrics, dietary management, exercise guidance, behavioral intervention, psychological support, medication-assisted management, remote physician follow-ups, and data analysis platforms. By integrating data on weight, BMI, body fat percentage, activity levels, sleep, dietary logs, and metabolic indicators, digital obesity management platforms help users establish sustainable healthy behaviors and provide dynamically adjusted plans tailored to individual needs. This service is widely applied in areas such as adult obesity management, pediatric obesity intervention, metabolic syndrome management, weight-loss medication support, and corporate wellness programs, representing a crucial shift in obesity care from traditional treatment toward prevention, intervention, and long-term management.

Driven by rising global obesity rates, the expanded use of GLP-1 weight-loss drugs, the digitalization of chronic disease management, the proliferation of telemedicine, and the upgrading of health-related consumption, Digital Obesity Management is evolving from simple weight-tracking tools into comprehensive weight-loss management ecosystems. Key opportunities currently lie in AI-driven dietary analysis, intelligent exercise guidance, data integration from wearable devices, support for GLP-1 drug therapy, remote nutritional counseling, psychological and behavioral interventions, and corporate wellness services. Core industry competitiveness is defined by AI algorithm accuracy, user behavior analysis capabilities, medically sound content frameworks, the service capacity of physicians and nutritionists, data integration capabilities, and the ability to retain users over the long term. Current industry pain points include insufficient long-term user adherence, significant individual variation in weight-loss outcomes, limited accuracy in dietary data collection, data silos, a shortage of professional medical resources, and high pressure regarding business model profitability. Solutions involve using AI for personalized dietary recognition and intervention, continuously collecting health data via wearables, establishing standardized management pathways based on medical guidelines, and integrating digital therapeutics, pharmacotherapy, nutritional management, and telemedicine services. Overall, the industry is upgrading from traditional weight-loss apps to comprehensive digital health management platforms that combine AI, medical care, behavioral management, and medication support.

This report presents a comprehensive overview of the global Digital Obesity Management market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Weight Tracking and Management Software
  • Ai-Based Dietary Analysis Software
  • Exercise Management Software
  • Health Data Analysis Platform
  • Digital Therapeutics (DTx) Platform
  • Others

Segment by Business Model

  • Subscription Model
  • Employer Health Program
  • Insurance-covered Model
  • Clinical Care Model

Segment by Application

  • Obesity Management for Adults
  • Obesity Management for Children and Adolescents
  • Obesity Management for the Elderly
  • Management of Obesity with Diabetes
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Digital Obesity Management market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Obesity Management for Adults, Obesity Management for Children and Adolescents, Obesity Management for the Elderly evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Digital Obesity Management Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.31B
2025
Forecast
$11.5B
2032
CAGR
9%
2025–2032
Régions
5
global
Key companies
WW InternationalNoomTeladoc HealthOmada HealthHims & Hers HealthFound HealthLark HealthMyFitnessPal
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Weight Tracking and Management SoftwareAi-Based Dietary Analysis SoftwareExercise Management SoftwareHealth Data Analysis PlatformDigital Therapeutics (DTx) PlatformOthers
By Application
Obesity Management for AdultsObesity Management for Children and AdolescentsObesity Management for the ElderlyManagement of Obesity with DiabetesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Weight Tracking and Management Software
  • 3.1.3 Ai-Based Dietary Analysis Software
  • 3.1.4 Exercise Management Software
  • 3.1.5 Health Data Analysis Platform
  • 3.1.6 Digital Therapeutics (DTx) Platform
  • 3.1.7 Others
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Obesity Management for Adults
  • 4.1.3 Obesity Management for Children and Adolescents
  • 4.1.4 Obesity Management for the Elderly
  • 4.1.5 Management of Obesity with Diabetes
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 WW International
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Noom
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Teladoc Health
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Omada Health
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Hims & Hers Health
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Found Health
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Lark Health
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 MyFitnessPal
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Lose It
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 HealthifyMe
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Lifesum
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 WellDoc
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Better Therapeutics
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Oviva AG
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Lifesum AB
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Liva Healthcare
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 CureApp Inc
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Asken Inc
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Alibaba Health Information Technology
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Boohee
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Digital Obesity Management market?
The global Digital Obesity Management market is estimated at US$ 6.31 billion in 2025 (base year) and is projected to reach US$ 11.47 billion by 2032.
How fast is the Digital Obesity Management market expected to grow?
The market is expected to grow at a CAGR of 9.0% from 2026 to 2032, expanding from US$ 6.31 billion in 2025 to US$ 11.47 billion in 2032, roughly 1.8 times its base-year value.
What does the Digital Obesity Management market cover?
Digital Obesity Management refers to a comprehensive health management model that utilizes technologies such as artificial intelligence (AI), big data, mobile health applications, wearable devices, telemedicine, and digital therapeutics to provide long-term, personalized, and intelligent management for individuals with obesity.
How is the Digital Obesity Management market segmented by type?
By type, the market is segmented into Weight Tracking and Management Software, Ai-Based Dietary Analysis Software, Exercise Management Software, Health Data Analysis Platform, Digital Therapeutics (DTx) Platform and Others.
What are the key applications of Digital Obesity Management?
Key applications covered include Obesity Management for Adults, Obesity Management for Children and Adolescents, Obesity Management for the Elderly, Management of Obesity with Diabetes and Others.
Which companies are profiled in the Digital Obesity Management market report?
Key players profiled include WW International, Noom, Teladoc Health, Omada Health, Hims & Hers Health, Found Health, Lark Health and MyFitnessPal, among 20 companies covered in total.
What geographies does the Digital Obesity Management market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Digital Obesity Management?
Driven by rising global obesity rates, the expanded use of GLP-1 weight-loss drugs, the digitalization of chronic disease management, the proliferation of telemedicine, and the upgrading of health-related consumption, Digital Obesity Management is evolving from simple weight-tracking tools into comprehensive weight-loss management ecosystems.
Who should buy the Digital Obesity Management market report?
The report is intended for manufacturers and solution providers, distributors and end users in Obesity Management for Adults, Obesity Management for Children and Adolescents and Obesity Management for the Elderly, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Digital Obesity Management market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.